Apyx Medical Corporation (APYX) return on equity (ROE)

Return on equity · fiscal 2025
-77.1%

Apyx Medical Corporation (APYX) earned a return on equity of -77.1% in fiscal 2025 (the year ended December 31, 2025). That is 88.0 percentage points higher than the -165.1% of fiscal 2024. Figures as of 17 Nov 2026, 23:17 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2025
-77.1%
Change on fiscal 2024
+88.0 pts
Highest on record
71.9%fiscal 2018
Lowest on record
-1149.1%fiscal 2014
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Apyx Medical Corporation return on equity (ROE), in more detail

Across the 17 fiscal years on record (2009–2025), the highest was 71.9% in fiscal 2018 and the lowest -1149.1% in fiscal 2014. The fiscal 2025 figure is higher than in 13% of the 16 earlier fiscal years on record, whose median is -23.0%.

History · 17 fiscal years

Return on equity by fiscal year

Apyx Medical Corporation return on equity (ROE), year by year

Apyx Medical Corporation (APYX) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
2025-77.1% 88.0 pts up
2024-165.1% 95.0 pts down
2023-70.1% 8.4 pts down
2022-61.7% 33.4 pts down
2021-28.3% 9.6 pts down
2020-18.7% 9.0 pts up
2019-27.7% 99.6 pts down
201871.9% 94.9 pts up
2017-23.0% 21.1 pts up
2016-44.0% 21.1 pts down
2015-22.9% 1126.1 pts up
2014-1149.1% 1126.3 pts down
2013-22.8% 25.4 pts down
20122.7% 2.2 pts up
20110.5% 7.5 pts up
2010-7.1% 9.9 pts down
20092.8%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

More on APYX

Apyx Medical Corporation, figure by figure

Apyx Medical Corporation (APYX) overview: price, valuation and scorecard

Apyx Medical Corporation return on equity (ROE): questions and answers

What is Apyx Medical Corporation's return on equity?

Apyx Medical Corporation (APYX) earned a return on equity of -77.1% in fiscal 2025 (the year ended December 31, 2025). That is 88.0 percentage points higher than the -165.1% of fiscal 2024.

Is Apyx Medical Corporation's return on equity high or low compared with its own history?

The fiscal 2025 figure is higher than in 13% of the 16 earlier fiscal years on record, whose median is -23.0%.

What are the highest and lowest return on equity figures on record for Apyx Medical Corporation?

Across the 17 fiscal years on record (2009–2025), the highest was 71.9% in fiscal 2018 and the lowest -1149.1% in fiscal 2014.

How is Apyx Medical Corporation's return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Apyx Medical Corporation (APYX) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/APYX/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.